All News

Found 64,949 articles

• PCOM: COVID-19 Hits Hard in Rural America

  6/18/2020

  While initial hot spots of COVID-19 were centered in dense urban areas, infections have rapidly expanded into suburban and rural settings – in areas with a population between 2,500 and 50,000 according to The Henry J. Kaiser Family Foundation.

• Chi-Med Announces Fruquintinib Granted U.S. FDA Fast Track Designation for Metastatic Colorectal Cancer

  6/18/2020

  Hutchison China MediTech Limited announces that the US FDA has granted Fast Track Designation for the development of fruquintinib, for the treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-vascular endothelial growth factor biological therapy, and, if RAS wild-type, an anti-epidermal growth factor receptor therapy.

• Coronavirus (COVID-19) Update: Daily Roundup - June 18, 2020

  6/18/2020

  The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic

• How to Stay Safe this Summer as COVID-19 Restrictions Lift

  6/18/2020

  As states lift some restrictions designed to protect public health against furthering the spread of COVID-19, people across the country are wondering how to safely engage in activities this summer such as gathering with friends, traveling and going to the beach.

• Lab Informatics Online Courses Now Live from CSols University

  6/18/2020

  In what is planned to be an ever-growing resource for laboratory informatics professionals everywhere, CSols, Inc., the premier laboratory informatics consultancy, has launched CSols University, with its first-ever online course, Creating a Lab Informatics Risk Assessment.

• IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

  6/18/2020

  IVERIC bio, Inc., announced the pricing of an upsized underwritten public offering of 24,535,720 shares of its common stock at a price to the public of $4.100 per share and, to certain investors in lieu of common stock, pre-funded warrants to purchase 1,914,280 shares of its common stock at a price to the public of $4.099 per pre-funded warrant, in each case less underwriting discounts and commissions.

• Mednet and AppBus Partner to Optimize Clinical Trials

  6/18/2020

  AppBus, an accelerator of business transformation, and Mednet, a provider of eClinical solutions for the global life sciences community, announced they have partnered together to address the rapidly evolving demands and requirements of clinical trials.

• More Than 80% Of Americans Report Nation's Future Is Significant Source Of Stress, Survey Says

  6/18/2020

  As protests continue, more than half of black adults say discrimination a significant stressor

• Rexahn and Ocuphire Enter into Definitive Merger Agreement

  6/18/2020

  Transaction to Create a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates

• Georgia-Based Healthcare Manufacturer, Marena, Launches Children's Masks For COVID-19 Response

  6/18/2020

  The Marena Group LLC, a Georgia-based medical device manufacturer, announced that it has immediately begun producing new non-surgical masks for children in response to the COVID-19 pandemic.

• Hepcidin Mimetic PTG-300 Receives U.S. FDA Orphan Drug Designation for the Treatment of Polycythemia Vera

  6/18/2020

  Protagonist Therapeutics, Inc. announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for PTG-300 for the treatment of polycythemia vera.

• Montefiore And Einstein Lead Major NYC Health Centers In Publishing Largest Body Of Data In The US About Pregnant Women And COVID

  6/18/2020

  Researchers at Montefiore Health System and Albert Einstein College of Medicine, in collaboration with four major New York City academic health centers, published the largest review to date of birth outcomes among women with SARS-CoV-2, the novel coronavirus.

• BeyondSpring Announces Proposed Public Offering of Ordinary Shares - June 18, 2020

  6/18/2020

  BeyondSpring Inc., a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, announced the launch of an underwritten public offering of its ordinary shares.

• Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering

  6/18/2020

  Brickell Biotech, Inc., a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, announced the pricing of an underwritten public offering of 17,500,000 shares of common stock or common stock equivalents and investor warrants to purchase up to an aggregate of 17,500,000 shares of common stock.

• Stereotaxis to Present at Cowen 5th Annual FutureHealth Conference

  6/18/2020

  Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced that David Fischel, Chairman and CEO, will present at the Cowen 5th Annual FutureHealth Conference on Thursday, June 25, 2020 at 10:15 am EDT.

• Santen and Orbis International Join Forces to Expand Access to Training for Eye Care Professionals through Telemedicine Platform

  6/18/2020

  Santen Pharmaceutical Co., Ltd. and Orbis International announced a partnership to develop a suite of digital training tools that will continue to help eye care professionals around the world build their skills.

• Righttime Medical Care Centers Offer Both COVID-19 and Antibody Testing

  6/18/2020

  The Maryland-based urgent care company has performed 11,000 COVID-19 tests and is now beginning to see an increase in non-COVID medical concerns

• ObvioHealth and Hôpital Paris Saint-Joseph Announce Partnership to Track COVID-19 in Oncology Patients

  6/18/2020

  ObvioHealth, a full-service virtual research organization, announces a partnership with La Foundation Hôpital Paris Saint Joseph to monitor COVID-19 prevalence and symptoms among the oncology patients of the Groupe Hospitalier Paris Saint Joseph.

• Abeona Therapeutics Announces Upcoming Data Presentations at the Society for Pediatric Dermatology 45th Annual Meeting

  6/18/2020

  Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that two abstracts related to its clinical program for recessive dystrophic epidermolysis bullosa (RDEB) will be presented at the upcoming Society for Pediatric Dermatology (SPD) 45 th Annual Meeting, to be held virtually during July 10-12, 2020. RDEB is a rare connective tissue disorder without an approved treatment, in which p

• Animal Healthcare Market - Growing Investments of Central and State Bodies in Animal Care and Veterinary Treatments

  6/18/2020

  The demand within the global animal healthcare market is set to touch new heights in the years to follow.